Impact of Glycemic Control on the Clinical Outcome in Diabetic Patients With Percutaneous Coronary Intervention : – From the FU-Registry –
スポンサーリンク
概要
- 論文の詳細を見る
Background: It is not yet clear whether glycemic control affects the clinical outcome of percutaneous coronary intervention (PCI) in diabetic patients. Methods and Results: This study compared the effects of glycemic control on the clinical outcome in 2 groups of patients with diabetes mellitus (DM) who underwent PCI: a poor-glycemic-control group, who showed greater than 6.9% HbA1c at the time of PCI (Pre-HbA1c) (`≥6.9 group, n=334 patients) and a good-glycemic-control group, who showed less than <6.9% at Pre-HbA1c (`<6.9 group, n=212 patients). The patients in the ≥6.9 group were further divided into 2 groups for further comparisons: a `DM control group and a `Poor control group. At follow-up (300 days), the incidence of major adverse cardiac event (MACE) was significantly (P<0.05) lower in the <6.9 group (18.4% vs. 26.2%). However, there was no difference in MACE between the DM control group and the Poor control group. In a multivariate analysis, there was no relationship between the incidence of MACE and Pre-HbA1c, Pre-HbA1c≥6.9% or the HbA1c difference (Pre-HbA1c-HbA1c at follow-up). Conclusions: Clinical outcomes in the <6.9 group were superior to those in the ≥6.9 group as pre-PCI glycemic control affected the baseline characteristics. The results suggested that glycemic control started at PCI was not associated with an improvement in the clinical outcome at follow-up. (Circ J 2011; 75: 791-799)
論文 | ランダム
- 57) 運動時の心拍数応答特性解析法による冠攣縮性狭心症の診断 : 特にCa^拮抗剤の影響 : 日本循環器学会第55回近畿地方会
- 29)右脚ブロックに関する臨床病理学的研究(第1報) : 老年者58例の剖検所見について : 第26回日本循環器学会関東・甲信越地方学会総会
- Risk Stratification Using a Combination of Heart-type Fatty Acid Binding Protein and Brain Natriuretic Peptide in Chronic Heart Failure Patients(Neurohumoral Factors 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- 229)トレッドミル負荷試験における心室性期外収縮の運動時心拍数との関係 : 日本循環器学会第54回近畿地方会
- 2)Captopril長期投与により変換酵素生成のinductionを起したと考えられる肺高血圧症の1例 : 日本循環器学会第103回関東・甲信越地方会